Page last updated: 2024-08-23

pravastatin and Chlamydia pneumoniae Infections

pravastatin has been researched along with Chlamydia pneumoniae Infections in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashi, J; Kikuchi, K; Maeda, N; Okada, K; Sawayama, Y; Shimizu, C; Tatsukawa, M	1
Furusyo, N; Hayashi, J; Maeda, S; Ohnishi, H; Okada, K; Sawayama, Y	1
Bloigu, A; Erkkilä, L; Haasio, K; Jauhiainen, M; Laitinen, K; Leinonen, M; Saikku, P; Tiirola, T	1
Belder, R; Braunwald, E; Breen, J; Cannon, CP; McCabe, CH	1

Trials

2 trial(s) available for pravastatin and Chlamydia pneumoniae Infections

Article	Year
Association of Chlamydia pneumoniae antibody with the cholesterol-lowering effect of statins. Atherosclerosis, 2003, Volume: 171, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Angiography; Antibodies, Bacterial; Blotting, Western; Carotid Artery Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin A; Immunoglobulin G; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Probucol; Risk Assessment; Severity of Illness Index; Treatment Outcome	2003
Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy. Fukuoka igaku zasshi = Hukuoka acta medica, 2006, Volume: 97, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Carotid Artery Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Disease Progression; Female; Hepatitis C; Humans; Male; Middle Aged; Pravastatin; Probucol	2006

Article

Year

Association of Chlamydia pneumoniae antibody with the cholesterol-lowering effect of statins.

Atherosclerosis, 2003, Volume: 171, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Angiography; Antibodies, Bacterial; Blotting, Western; Carotid Artery Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin A; Immunoglobulin G; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Probucol; Risk Assessment; Severity of Illness Index; Treatment Outcome

2003

Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.

Fukuoka igaku zasshi = Hukuoka acta medica, 2006, Volume: 97, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Carotid Artery Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Disease Progression; Female; Hepatitis C; Humans; Male; Middle Aged; Pravastatin; Probucol

2006

Other Studies

2 other study(ies) available for pravastatin and Chlamydia pneumoniae Infections

Article	Year
Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice. International journal of antimicrobial agents, 2007, Volume: 29, Issue:6 Topics: Animals; Chlamydophila Infections; Chlamydophila pneumoniae; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Mice; Mice, Inbred Strains; Pravastatin	2007
Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial. The American journal of cardiology, 2002, Apr-01, Volume: 89, Issue:7 Topics: Angina, Unstable; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol, LDL; Double-Blind Method; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multicenter Studies as Topic; Myocardial Infarction; Pneumonia, Bacterial; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design	2002

Article

Year

Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice.

International journal of antimicrobial agents, 2007, Volume: 29, Issue:6

Topics: Animals; Chlamydophila Infections; Chlamydophila pneumoniae; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Mice; Mice, Inbred Strains; Pravastatin

2007

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial.

The American journal of cardiology, 2002, Apr-01, Volume: 89, Issue:7

Topics: Angina, Unstable; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol, LDL; Double-Blind Method; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multicenter Studies as Topic; Myocardial Infarction; Pneumonia, Bacterial; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design

2002